Dec 2, 2024, 08:29 by

Dec 2, 2024, 08:29 by

Dec 2, 2024, 08:29 by

Clinion’s groundbreaking platform is revolutionizing clinical trials, demonstrating how cutting-edge technology is expediting the journey of new therapies to market.

Nov 27, 2024, 09:10 by

The government announced the BioE3 (Biotechnology for Economy, Environment and Employment) policy, a strategic plan to take India to the next era of industrialization through advanced biomanufacturing. Enhancing India’s biomanufacturing capabilities by integrating science, technology, engineering, and manufacturing will enable institutions, universities, startups, and industries in India to participate in innovation, thereby supporting the growth of the upstream bioprocessing market.

Nov 26, 2024, 08:29 by

PhaseV's Machine Learning Platforms are Being Used by Top Global Pharma Companies to Guide Adaptive Trials, Precision Medicine, and Indication Selection Across Multiple Therapeutic Areas

Nov 26, 2024, 08:26 by

Nov 26, 2024, 01:00 by User Not Found

Clinical Research News | Alpha-9 funds targeted radiopharmaceuticals; Evommune pursues chronic urticaria and atopic dermatitis; Agomab Therapeutics advances lead candidate in Crohn’s disease (FSCD); and more.

Nov 25, 2024, 08:29 by

Biopharma PEG Scientific Inc. is offering a 30% Thanksgiving discount on select monodispersed PEGs, including mPEG36-NH2, N3-PEG6-OH, and N3-PEG11-NH2. These high-purity, GMP-grade products are ideal for applications like PEGylation, ADC linkers, and PROTAC linkers. The offer is valid until December 4, 2024, at 23:59 EST. Contact us to take advantage of this limited-time promotion.

Nov 25, 2024, 01:00 by User Not Found

Clinical Research News | GeneDx announced GeneDx Discover, a first-of-its-kind data visualization tool, which provides biopharmaceutical companies access to deidentified and aggregated genetic data—powered by GeneDx’s database—to improve all stages of drug development; Critical Path Institute announced a landmark initiative, Gender Equitable Medicines for Parkinson's Disease, dedicated to globally advancing actionable research on how Parkinson's disease uniquely impacts women and individuals across the sex and gender spectrum; and more.

Nov 22, 2024, 08:26 by

CIRCOR International, Inc., a leading manufacturer and marketer of differentiated technology products and sub-systems, highlights its new BB PEP Series pumps, engineered for high-precision performance in polymer extrusion applications. With a focus on consistent, accurate performance, the BB PEP Series addresses critical demands such as uniformity, durability, and ease of maintenance in the chemical, industrial and life sciences industries.

Nov 22, 2024, 08:26 by

Industry recognition highlights company’s diverse portfolio mix, flexibility and ease of deployment, and data integration capabilities, driving real-time review and insights

Nov 22, 2024, 01:00 by User Not Found

Clinical Research News | The global biosimilars market is experiencing substantial growth, valued at $29.45 billion in 2023, it is projected to reach $150.3 billion by 2033 (CAGR of 17.7%). This upward trajectory is primarily driven by the ability of biosimilars to offer safe, clinically effective, and cost-effective alternatives to reference biologics, expanding patient access to treatments for the ever-rising number of chronic and severe illnesses.

Nov 21, 2024, 08:14 by

In November 2024, a $60 million fundraising transaction for Series E preferred stock was successfully closed by Beta Bionics, Inc., a trailblazing leader in the creation of cutting-edge diabetes treatment solutions.

Nov 20, 2024, 10:26 by

The MiSeq i100 Series of sequencing equipment was introduced by Illumina, a multinational corporation dedicated to DNA sequencing and array-based technologies. The new systems are designed to improve next-generation sequencing (NGS) capabilities for labs by providing quick turnaround and user-friendliness.

Nov 20, 2024, 01:00 by User Not Found

Clinical Research News | arvard scientists, led by Dr. Marinka Zitnik, have developed an AI-based tool, TxGNN, to identify drug repurposing opportunities for diseases lacking effective treatments. The AI model harnesses a novel approach by focusing on multiple diseases simultaneously, allowing insights from well-documented conditions to be applied to rare diseases with sparse data.

Nov 19, 2024, 11:37 by

Sakura Finetek Europe and MEDIPATH announced their collaboration to enhance cancer diagnostics and thus contribute to improved patient therapeutic management.

Nov 19, 2024, 01:00 by User Not Found

Clinical Research News | Pharma leaders took on clinical trial quality in a panel discussion at the SCOPE Europe conference last month in Barcelona. While technologies change, the conversation underscored a central truth: the push for quality in clinical research remains as vital, yet as challenging, as ever.

Nov 18, 2024, 08:25 by

City Therapeutics, which uses next-generation engineering of small interfering RNAs (siRNAs) to drive improvements in RNA interference (RNAi)--based therapeutics, has announced its debut along with a $135 million Series A funding.

Nov 15, 2024, 09:19 by

Coronado Research announced today that Alexander McCormick has been appointed as Chief Commercial Officer.

Nov 14, 2024, 08:43 by

Greenphire, a leading innovator in software solutions for improving clinical research site performance and participant satisfaction, announced the addition of product strategy expert Derek Bluestone as its new CPO.